一个全面的战略,以消除单克隆抗体的流行病准备
Christian Marx1, Ralf Piotrowiak2, Thomas Schirrmann3
1Institute for Micro and Nanotechnologies (MacroNano®), Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.
mAbs
|October 13, 2025
概括
单克隆抗体 (mAbs) 对于疫苗之外的流行病准备至关重要. 包括研究,制造和分销在内的全面的mAb战略确保了对不断变化的病毒威胁的快速部署.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 核酸疫苗在COVID-19期间至关重要,但并不能提供普遍的保护.
- 治疗干预措施,如单克隆抗体 (mAbs),对于预防和治疗至关重要,特别是在弱势群体.
- 由于病毒的快速演变,抗病毒mAbs面临着挑战,需要创新的策略.
研究的目的:
- 突出单克隆抗体 (mAbs) 在流行病准备中的关键作用.
- 为开发,制造和部署mAbs.提出一个全面的战略.
- 确保对不断演变的病毒标的持续治疗疗效.
主要方法:
- 疫苗和治疗干预的有效性的回顾性分析.
- 识别当前mAb发展和适应的挑战.
- 提出创新策略的建议,包括准保存的表征物和多mAb配方.
主要成果:
- 疫苗本身不足以提供全面的流行病保护.
- 病毒变异的出现经常会降低现有的抗病毒药物的有效性.
- 准保存的表位和使用多mAb配方可以保持治疗疗效.
结论:
- 一个全面的mAb战略是未来疫情准备的基石.
- 这一战略应包括研发支持,有弹性的区域制造业和协作网络.
- 开发,生产和分销mAb的标准化程序是快速部署的关键.
相关概念视频
Antibody Actions
2.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.2K
Humoral Immune Responses
83.1K
Overview
83.1K
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K


